MedTrace Logo

Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis

NCT03126201 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2018-02-19

No results posted yet for this study

Summary

Focal segmental glomerulosclerosis (FSGS) is one of the most common primary glomerular diseases leading to end stage renal disease. In this study, our aim is to evaluate the effects of histopathological, clinical, and laboratory features of patients with primary FSGS on the disease progression.

Conditions

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Yasar Caliskan, MD · Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-09-30
Completion
2017-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03126201 on ClinicalTrials.gov